Dz13: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{EH}} | {{EH}} | ||
'''Dz13''' is an experimental treatment developed by | '''Dz13''' is an experimental treatment developed by Australian scientists which aims to combat a range of illnesses from [[diabetes]] to [[Heart Disease|heart disease]] and [[cancer]]. | ||
==How it works== | ==How it works== | ||
Revision as of 13:26, 7 May 2009
|
WikiDoc Resources for Dz13 |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Dz13 at Clinical Trials.gov Clinical Trials on Dz13 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Dz13
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Dz13 Risk calculators and risk factors for Dz13
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Dz13 is an experimental treatment developed by Australian scientists which aims to combat a range of illnesses from diabetes to heart disease and cancer.
How it works
The treatment works by targeting "c-Jun", a disease causing gene found in diseased blood vessels, eyes, lungs, joints and the stomach, removing it from the DNA in a cell. It has been proven to have a positive effect on skin cancer in patients.[citation needed]